GlassScriptPhysician profile
Renee L Mackey
NPI 1013158658
$5,250.20
in general payments reported to CMS, 2019-2025
34 companies · $308 in 2025
The $308 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $605 · 2020: $692 · 2021: $1,145 · 2022: $1,657 · 2023: $471 · 2024: $372 · 2025: $308.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,151.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,150.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,094.64 | 2019-2023 | Renasys Go V2 Home, Pico, Collagenase Santyl |
| Organogenesis INC. | $915.02 | 2019-2025 | Puraply, Apligraf, Puraply Wound Matrix |
| Treace Medical Concepts, INC. | $743.19 | 2022 | |
| Paratek Pharmaceuticals, INC. | $356.56 | 2021-2025 | Nuzyra |
| Abbvie INC. | $270.95 | 2021-2024 | |
| Melinta Therapeutics, LLC | $185.06 | 2019-2022 | |
| Kerecis Limited | $159.26 | 2021-2022 | |
| Horizon Therapeutics Plc | $154.02 | 2021-2022 | |
| Mimedx Group, INC. | $141.98 | 2024 | |
| Amniox Medical, INC. | $124.94 | 2020 | |
| Medtronic Vascular, INC. | $124.62 | 2019 | |
| Integra Lifesciences Corporation | $99.04 | 2020-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Boston Scientific Corporation | $83.41 | 2022 | |
| Polynovo North America LLC | $76.81 | 2024-2025 | Novosorb Btm |
| Misonix INC | $72.88 | 2019-2020 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $67.20 | 2024-2025 | Activ.A.C. |
| Nevro Corp. | $50.18 | 2022 | |
| Amgen INC. | $47.30 | 2024 | Krystexxa |
| Aroa Biosurgery Incorporated | $45.60 | 2019-2024 | |
| Nabriva Therapeutics, Plc | $44.44 | 2021-2022 | |
| Medline Industries LP | $37.66 | 2019-2020 | |
| Osiris Therapeutics INC. | $36.31 | 2019 | |
| Stryker Corporation | $35.46 | 2019 | |
| Merck Sharp & Dohme LLC | $35.38 | 2019 | |
| Orthofix Medical, INC. | $31.12 | 2019-2023 | Physio-Stim |
| Tactile Systems Technology INC | $31.07 | 2022-2025 | Flexitouch Plus, Nimbl |
| Reapplix INC. | $28.86 | 2022 | |
| Kci USA, INC. | $26.77 | 2022-2023 | Activ.A.C. |
| Urgo Medical North America, LLC | $26.06 | 2025 | Urgoclean Ag |
| Osteomed LLC | $24.43 | 2019 | |
| Biopro, INC. | $23.71 | 2023 | |
| Allergan, INC. | $22.44 | 2019 | |
| Averitas Pharma INC. | $18.59 | 2023 | Qutenza |
| Triad Life Sciences INC. | $15.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Renee Mackey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.